These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 203216)

  • 1. Immunoprophylaxis of experimental cytomegalovirus infection.
    Minamishima Y
    Ann Microbiol (Paris); 1977 Oct; 128(3):399-407. PubMed ID: 203216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylaxis against cytomegalovirus disease.
    Adler SP
    Scand J Infect Dis Suppl; 1995; 99():105-9. PubMed ID: 8668931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine model for immunoprophylaxis of cytomegalovirus infection. I. Efficacy of immunization.
    Minamishima Y; Eizuru Y; Yoshida A; Fukunishi R
    Microbiol Immunol; 1978; 22(11):693-700. PubMed ID: 85239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice.
    Roback JD; Su L; Newman JL; Saakadze N; Lezhava LJ; Hillyer CD
    Transfusion; 2006 Jun; 46(6):889-95. PubMed ID: 16734804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward an elusive goal: current status of cytomegalovirus vaccines.
    Schleiss MR; Heineman TC
    Expert Rev Vaccines; 2005 Jun; 4(3):381-406. PubMed ID: 16026251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current prospects for immunization against cytomegaloviral disease.
    Adler SP
    Infect Agents Dis; 1996 Jan; 5(1):29-35. PubMed ID: 8789597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
    Schleiss MR
    J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of ocular murine cytomegalovirus infection.
    Hayashi K; Kurihara I; Uchida Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity to murine cytomegalovirus.
    Howard RJ; Mattsson DM; Seidel MV; Balfour HH
    J Infect Dis; 1978 Nov; 138(5):567-604. PubMed ID: 213500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
    Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
    J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic strategies against cytomegalovirus infection.
    Ranger-Zisman B; Palmon A; Blagerman S; Tel-Or S; Benharroch D; Pecht M; Trainin N; Burstein Y
    Nat Immun; 1995 Sep; 14(5-6):250-61. PubMed ID: 8933819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
    Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
    J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus induces T-cell independent apoptosis in brain during immunodeficiency.
    Reuter JD
    J Clin Virol; 2005 Mar; 32(3):218-23. PubMed ID: 15722026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines.
    Sandford GR; Burns WH
    J Infect Dis; 1988 Sep; 158(3):596-601. PubMed ID: 2842407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.
    Schleiss MR; Lacayo JC; Belkaid Y; McGregor A; Stroup G; Rayner J; Alterson K; Chulay JD; Smith JF
    J Infect Dis; 2007 Mar; 195(6):789-98. PubMed ID: 17299708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match.
    Webb JR; Lee SH; Vidal SM
    Genes Immun; 2002 Aug; 3(5):250-62. PubMed ID: 12140743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.